Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...

In sixty years of career, he spoke about racism, religion, sex, hunger, death penalty, war, anorexia, violence. The ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

McKinsey & Company’s prestigious two-day workshop Bower Forum is a unique platform for a small group of CEOs or Chairpersons ...

Moderna made a lot of money during the pandemic, but its post-pandemic prospects look bleak. Sales in 2025 could be down more than half from 2024 levels, according to Moderna's latest guidance ...

Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...

Moderna projects $1.5 billion-$2.5 billion in 2025 revenue, with cash and investments estimated at $6 billion by year-end. 2024 product sales are approximately $3 billion-$3.1 billion, driven by $ ...

Moderna (MRNA) shares are plunging after the company cut its 2025 sales guidance. A number of retailers updated their quarterly guidance, including Lululemon (LULU), Macy's (M), and Abercrombie ...

Wednesday's Forbes Daily features a promising norovirus vaccine, Trump's proposed "External Revenue Service," TikTok's price ...

Elon Musk could target the F-35 when looking for savings at his newly created quasi-government consultancy Department of ...

Meta Platforms is ending fact-checking and speech restrictions across Facebook and Instagram, as Chief Executive Mark Zuckerberg embraces a second Trump presidency. Starting in the U.S., Meta will ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...